Blog
RSS FeedPosted by Michael Wonder on 11 Sep 2019
Germany may have the answer for reducing drug prices
11 September 2019 - American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s ...
Posted by Michael Wonder on 10 Sep 2019
Drug prices get Washington’s attention ahead of 2020 election
10 September 2019 - Pelosi, Grassley push legislative measures, while Trump indicates he will issue an executive action. ...
Posted by Michael Wonder on 10 Sep 2019
For drug companies, there are real costs to unpopularity
10 September 2019 - A familiar headache for drug investors is likely to soon reappear. ...
Posted by Michael Wonder on 10 Sep 2019
Drug prices keep rising amid political pressure, but not as fast
10 September 2019 - Prices for the majority of drugs in the U.S. have started to rise more slowly, likely ...
Posted by Michael Wonder on 10 Sep 2019
Greg Hunt's medical deals come back to bite him
11 September 2019 - Health minister Greg Hunt’s efforts to rein in growth in private health insurance premiums looks like ...
Posted by Michael Wonder on 10 Sep 2019
Canada releases final amendments to patented medicines pricing regulations
9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 10 Sep 2019
Pelosi drug pricing plan would let government negotiate most costly medicines
9 September 2019 - The government would be allowed to directly negotiate the prices for some of the most expensive ...
Posted by Michael Wonder on 09 Sep 2019
Novo Nordisk launching additional US insulin affordability offerings in January 2020
6 September 2019 - $99 Cash Card Program provides 3,000 - 3,600 units of any combination of Novo Nordisk analog insulins ...
Posted by Michael Wonder on 08 Sep 2019
Trudeau’s drug price overhaul is set to cost drug makers billions
6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...
Posted by Michael Wonder on 07 Sep 2019
It’s time for Congress to go all in on drug pricing reform
6 September 2019 - The partisan stars are appear to be aligned in Washington on passing federal drug pricing reform, ...
Posted by Michael Wonder on 05 Sep 2019
What is the value of market-wide health care price transparency?
5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...
Posted by Michael Wonder on 05 Sep 2019
A bipartisan effort: States pass record number of laws to reel in drug prices
5 September 2019 - Whether Congress will act this year to address the affordability of prescription drugs – a high ...
Posted by Michael Wonder on 05 Sep 2019
Medicare drug price negotiation — why now . . . and how
4 September 2019 - A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and ...
Posted by Michael Wonder on 04 Sep 2019
Proposals to redesign Medicare Part D — easing the burden of rising drug prices
4 September 2019 - Amid concerns about high drug prices, policy makers are considering options for modifying the Medicare Part D ...
Posted by Michael Wonder on 04 Sep 2019
Capital Rx to inject transparency in prescription drug prices
4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...